Quantitative Analysis of Human Telomerase Reverse Transcriptase in Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-1821PMID 16609017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative Assessment of Telomerase Activity and Human Telomerase Reverse Transcriptase Messenger RNA Levels in Pancreatic Juice Samples for the Diagnosis of Pancreatic Cancer

  2005cited by this paper
• In vivo regulation of telomerase activity and telomere length

  2005cited by this paper
• A new molecular biology approach in morphology: basic method and application of laser microdissection

  2004cited by this paper
• A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors

  2004cited by this paper
• Strong Telomerase Activity of B Lymphocyte from Mesenteric Lymph Nodes of Patients with Inflammatory Bowel Disease

  2003cited by this paper
• Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.

  2002cited by this paper
• Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma

  2002cited by this paper
• Intraductal Papillary-Mucinous Tumor of the Pancreas Concomitant with Ductal Carcinoma of the Pancreas

  2002cited by this paper
• Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.

  2001cited by this paper
• Preoperative diagnosis of intraductal papillary‐mucinous tumors of the pancreas with attention to telomerase activity

  2001cited by this paper
• Diagnostic application of CD44 variant expression in pancreatic juice for detection of pancreatic neoplasm.

  2001influential reference
• Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.

  2000cited by this paper
• Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.

  2000cited by this paper
• Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations

  1999cited by this paper
• Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.

  1999cited by this paper
• Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.

  1997cited by this paper
• Telomerase activity is detected in pancreatic cancer but not in benign tumors.

  1997cited by this paper
• Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.

  1997cited by this paper
• Screening for disease.

  1997cited by this paper
• The national cancer data base report on pancreatic cancer

  1995cited by this paper
• Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

  1993cited by this paper
• Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

  1993cited by this paper
• Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis.

  1992cited by this paper
• Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique

  1992cited by this paper
• Pancreatic carcinoma.

  1992cited by this paper
• Cytologic criteria for the diagnosis of pancreatic carcinoma.

  1985cited by this paper
• Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater

  1982cited by this paper
• Screening for Disease

  1969cited by this paper

• Molecular assessment of endoscopically collected pancreatic juice and duodenal fluid from patients with pancreatic diseases

  2022cites this paper
• Inhibition of hTERT in pancreatic cancer cells by pristimerin involves suppression of epigenetic regulators of gene transcription

  2017cites this paper
• Telomerase Activity as a Marker for Differential Diagnosis of Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis

  2016influential citation
• Clinical Impact of the KL-6 Concentration of Pancreatic Juice for Diagnosing Pancreatic Masses

  2015cites this paper
• Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells

  2015cites this paper
• Diagnostic Investigation Using Pancreatic Juice

  2014cites this paper
• Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways

  2014cites this paper
• Intraductal papillary mucinous neoplasms of the pancreas.

  2014cites this paper
• Pancreatic Cancer: Clinical Significance of Biomarkers

  2013cites this paper
• Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae

  2013cites this paper
• Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia

  2010cites this paper
• MUC1 Is a Useful Molecular Marker for Malignant Intraductal Papillary Mucinous Neoplasms in Pancreatic Juice Obtained From Endoscopic Retrograde Pancreatography

  2010cites this paper
• High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

  2010cites this paper
• Diagnostic and prognostic biomarkers in pancreatic carcinoma.

  2009cites this paper
• Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic Malignancy

  2009influential citation
• Detection of Pancreatic Carcinomas by Imaging Lactose-Binding Protein Expression in Peritumoral Pancreas Using [18F]Fluoroethyl-Deoxylactose PET/CT

  2009cites this paper
• Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas.

  2008cites this paper
• Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.

  2008cites this paper
• Molecular markers of pancreatic cancer: development and clinical relevance

  2008cites this paper
• Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas

  2008cites this paper
• Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens

  2008cites this paper
• Molecular pathogenesis of pancreatic cancer: advances and challenges.

  2007cites this paper
• S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples

  2007cites this paper